Could These 3 Biotechs Help Fight the MERS Virus?
Inovio Pharmaceuticals, Novavax, and Nanoviricides are developing treatments for the deadly MERS virus. Here’s what you need to know.
One Year Follow-Up From RSV F-Protein Vaccine Candidate Phase 1 Elderly Trial Demonstrates Sustained
One Year Follow-Up From RSV F-Protein Vaccine Candidate Phase 1 Elderly Trial Demonstrates Sustained Levels of Immune Response
Key Takeaways From Novavax's First-Quarter Earnings
Here's what you need to know about Novavax's first-quarter earnings report.
5 of Last Week's Biggest Winners
These five stocks posted double-digit percentage gains.
Novavax's VP of R&D Says Production of MERS Vaccine is Analagous to Situation Described in NEJM Pape
Novavax's VP of R&D Says Production of MERS Vaccine is Analagous to Situation Described in NEJM Paper on H7n9
Why XOMA, Zillow, and Novavax Are Today's 3 Best Stocks
Strong earnings reports help push the S&P 500 higher for the ninth time in 11 sessions, as XOMA, Zillow, and Novavax lead all stocks to the upside.
Why Novavax Inc. Shares Took Flight
Positive top-line results from a midstage RSV vaccine study send Novavax shares higher, but here's what investors should really be focused on.